3 patient evaluations for Trastuzumab

Sort by: Most recent

Dec 14, 2014 (Started Mar 20, 2014)

  • Effectiveness
    Major (for breast cancer)
  • Side effects
    Severe (left ventricular systolic dysfunction)
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 440 mg Every 3 Weeks

Dec 13, 2014 (Started Mar 20, 2014)

  • Effectiveness
    Major (for breast cancer)
  • Side effects
    Severe (left ventricular systolic dysfunction)
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 440 mg Every 3 Weeks

Nov 1, 2014 (Started Mar 20, 2014)

  • Effectiveness
    Major (for breast cancer)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 440 mg Every 3 Weeks

Aug 14, 2014 (Started Mar 20, 2014)

  • Effectiveness
    Major (for breast cancer)
  • Side effects
    Severe (left ventricular systolic dysfunction)
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 440 mg Weekly
Advice & Tips: Administered through pic line along with chemo then by injection every 3 weeks after chemo finished. (This 'finds' any stray cancer cells and kills them.) Hercepin quite literally saved my life. My tumour not only shrunk but completely disappeared after 4 doses.
  • 0 helpful marks

Jun 26, 2011 (Started Mar 11, 2009)

  • Effectiveness
    Major (for breast cancer)
  • Side effects
    Moderate (decreased sex drive (libido), headaches with eye discomfort, fatigue)
  • Adherence
    Always
  • Burden
    Somewhat hard to take
Dosage: 60 min Monthly
Advice & Tips: listen to your body and rest when needed
Side effects: fatigue, headaches with eye discomfort, decreased sex drive (libido)
  • 1 helpful mark

Aug 13, 2009 (Started Aug 29, 2008)

  • Effectiveness
    Moderate (for breast cancer)
  • Side effects
    Mild (sinus congestion)
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 580 mL Every Other Week
Cost: < $25 monthly
Side effects: sinus congestion
  • 0 helpful marks
Last updated:
Showing 3 of 3 patient evaluations for Trastuzumab
See more data on Trastuzumab